Insider · CIK 0001867998
David Silberman
Files at CGEN (COMPUGEN LTD), ORMP (ORAMED PHARMACEUTICALS INC.). First filing -, latest -.
In brief
David Silberman files SEC Form 4 as CFO at CGEN (COMPUGEN LTD), and also at ORMP (ORAMED PHARMACEUTICALS INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Silberman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | CGEN COMPUGEN LTD | AGrant or award Ordinary Shares | +19,500 | $0.00 | $0 | 55,000 | Jul 30, 2026 |
| Jul 29, 2026 | CGEN COMPUGEN LTD | AGrant or award Share Option (right to buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jul 30, 2026 |
| Jan 4, 2024 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +136,500 | - | - | 366,500 | Jan 8, 2024 |
Questions about David Silberman
Answered from the filings on this page, as of the latest one.
Is David Silberman buying or selling?
David Silberman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Silberman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Silberman has 0.
Where does David Silberman file Form 4?
David Silberman has filed Form 4 at CGEN (COMPUGEN LTD) as Chief Financial Officer; ORMP (ORAMED PHARMACEUTICALS INC.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.